Sodium salicylate enhances the expression of cyclooxygenase-2 in endotoxin-stimulated human mononuclear cells (Q43832367)

27 November 2017

Sodium salicylate enhances the expression of cyclooxygenase-2 in endotoxin-stimulated human mononuclear cells (English)

1 reference

27 November 2017

1 reference

1 reference

4

1 reference

27 November 2017

Amann R

1

1 reference

27 November 2017

Egger T

series ordinal

2

1 reference

27 November 2017

Schuligoi R

series ordinal

3

1 reference

27 November 2017

Peskar BA

series ordinal

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

European Journal of Pharmacology

27 November 2017

1 reference

27 November 2017

433

1 reference

27 November 2017

1

1 reference

27 November 2017

129-134

1 reference

The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Salicylate-enhanced activation of transcription factors induced by interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Antiinflammatory action of salicylates: aspirin is not a prodrug for salicylate against rat carrageenin pleurisy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Salicylates, nitric oxide, malaria, and Reye's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Aspirin enhances myocardial inducible nitric oxide synthase activity in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Role of interferon regulatory factor-1 and mitogen-activated protein kinase pathways in the induction of nitric oxide synthase-2 in retinal pigmented epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E(2) synthesis in murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

On the specificity of antisera against prostaglandins A2 and E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Inhibition of NF-kappa B by sodium salicylate and aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Aspirin and salicylate enhances the induction of inducible nitric oxide synthase in cultured rat smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Lipopolysaccharide-induced expression of prostaglandin H synthase-2 in alveolar macrophages is inhibited by dexamethasone but not by aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostagl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Effects of aspirin-like drugs on nitric oxide synthesis in rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Sodium salicylate inhibits macrophage TNF-alpha production and alters MAPK activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

Both p38alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1beta in rat glomerular mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901488-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)01488-1

1 reference

27 November 2017

1 reference